Study on Serum Biomarkers Screening for Gastric Cancer Using SELDI-TOF-MS Technology
Wen-jing WANG,Cha-zhen LIU,Ping LIAO,Pei-yun ZHU,Zhi-wen LUO,Guo-xing LIU,Liang ZHU,Cui-qin XIANG,Wei Lu
DOI: https://doi.org/10.3969/j.issn.1006-3617.2007.02.005
2007-01-01
Abstract:[Objective] To discover new serum biomarkers of gastric cancer for early detection. [Methods] Surface-enhanced laser desorption/ionization time-of-flight mass spectroscopy(SELDI-TOF-MS)was used to generate proteomic spectra of 32 patients diagnosed as gastric adenocarcinoma, 22 patients as peptic ulcer, 32 patients as gastritis, and 30 normal persons. Then the spectra were analyzed with Ciphergen Biosystem's Software and a new Biomarker Pattern's Software. [Results] Five masses with an average mass of 2953, 3 267, 5 341, 5912, 5927 were up-regulated in gastric cancer compared with normal persons, and four masses of 4059, 4213, 4270, 7 160 were down-regulated. In these masses, 4213, 5341, 5912, 7 160 masses have higher mean peak intensity. These 4 masses also changed significantly in PU and GS. Peak 5912 is the most interesting protein with a sensitivity of 81.25%, and specificity of 56.67%. Peak 4059 is a small but consistent peak which can be clearly seen from control samples but disappears in patient samples. Combination of three markers (4 059, 5 341, 5912) or (3 267, 4059, 5 341) could distinguish effectively gastric cancer with normal persons. [Conclusion] These low molecular weight serum proteins may be hopeful biomarkers which can be help to diagnose gastric cancer.